Weakness
16
0
0
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
18.8%
3 terminated out of 16 trials
75.0%
-11.5% vs benchmark
6%
1 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients
Treatment of Muscle Weakness in Critically Ill Patients
Early Cycloergometric Physiotherapy in Critically Ill Patients With Invasive Mechanical Ventilation
Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure
Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients
Effects of the Cross-Training in Patients With Multiple Sclerosis
Muscle Atrophy in Sepsis
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Benefit of CoQ-10 in Patients on Statins
Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy
Evaluation of Thermal-Aided Muscle Stimulation
Effect of Therapeutic Modalities on the Physical Fitness and Functional Capacity in Critical Patient
Utility of the History and Physical Exam in the Emergency Department
Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs
A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke